Adagio Medical Holdings (ADGM) Debt to Equity (2023)

Adagio Medical Holdings (ADGM) reported Debt to Equity of -$0.01 for Q4 2023.

Adagio Medical Holdings (ADGM) Debt to Equity (2023) Analysis & Trends

Adagio Medical Holdings (ADGM) has 1 years of Debt to Equity data on file, last reported at -$0.01 in Q4 2023.

  • Debt to Equity for Q4 2023 came in at -$0.01, changed N/A year-over-year; the trailing twelve-month figure through Dec 2023 was -$0.01 (changed N/A YoY), and the FY2023 annual result was -$0.01, changed N/A from the prior year.
  • Debt to Equity steadied at -$0.01 in Q4 2023 per ADGM's latest filing.
  • Over five years, Debt to Equity peaked at -$0.01 in Q4 2023 and troughed at -$0.01 in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 0.65
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 0.64
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 0.57
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 0.42
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 0.06
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 0.71
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 0.95
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 0.27
10 Adagio Medical Holdings 15.88 Mn 2.97 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2023 -0.01